Cipeplus FM Italia is a topical solution for the care and protection of animals, contained in a practical 1000 ml bottle. It is designed to facilitate administration and ensure effective anti-parasitic action.
The product stands out for its specific formulation which allows simple and direct application on animal skin, promoting long-lasting protection against fleas, ticks and other external parasites.
Thanks to its one liter format, it is ideal for use on multiple animals or for repeated treatments, ensuring a continuous and reliable approach to parasite control.
The balanced composition makes the product suitable for different types of skin and can be used without risks in compliance with the recommended doses and veterinary indications.
Therapeutic Indications
Cipeplus FM Italia is indicated for the treatment and prevention of infestations by fleas, ticks and other ectoparasites in various animal species, with particular focus on dogs and cats. The action of the product helps to eliminate existing parasites and prevent new infestations, ensuring effective and continuous protection.
It is particularly suitable in situations of acute infestations but also as a preventive measure during periods of increased activity of external parasites, such as the hot and humid seasons which favor the proliferation of fleas and ticks.
The solution is also useful in integrated protocols for the management of flea allergy dermatitis (FAD), as it helps to reduce the presence of parasites responsible for skin irritation and allergic reactions in sensitive animals.
It can also be used in contexts of prevention of vector-borne diseases, where limiting contact between parasites and animal hosts is essential to reduce the risk of secondary infections.
Composition
The product contains a carefully balanced mixture of active ingredients effective in eliminating and preventing parasitic infestations. The components include substances with acaricidal, insecticidal and repellent action, selected for their effectiveness and safety of use.
Within the formulation there are also excipients that facilitate topical application, improving the penetration of the active ingredients and ensuring excellent skin tolerability. The composition is designed to minimize the risk of irritation and allergies, making the product also suitable for sensitive subjects.
The contents of the 1000 ml bottle are homogeneous and stable over time, ensuring that each application maintains the efficacy and safety characteristics envisaged during the production phase.
The absence of aggressive preservatives or irritating substances confirms the attention towards animal health and well-being, promoting respectful treatment of the skin and fur.
Contraindications
Do not use the product in animals with known hypersensitivity or allergy to one or more components of the formulation. In such cases, the application could cause unwanted cutaneous or systemic reactions requiring prompt veterinary intervention.
It is not recommended to use the solution on very young animals, with damaged skin or with pre-existing skin pathologies without prior consultation with the veterinary doctor, to avoid complications due to possible absorption or local reactions.
Inappropriate or excess use can increase the risk of side effects and compromise the animal's health, therefore it is essential to respect the doses and methods of application recommended by the veterinarian.
It is also recommended to avoid contact of the product with the eyes and mucous membranes of animals to prevent acute irritation, and to wash hands after each application to ensure the safety of those administering the treatment.
Safety of the drug for the species
Cipeplus FM Italia has been formulated and tested to guarantee a good safety profile in the species for which it is indicated, mainly dogs and cats. However, it is important to underline that safety depends on the correct use of the product according to the indications given.
Controlled exposure to active ingredients ensures that animals receive the necessary protection without incurring significant risks. In the case of inge